Prevalence
Clinical
features
Differential
Diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Investigations |
- ANCA and ASCA (anti-Saccharomyces cerevisiae antibodies) in new cases a
c

Why?
A positive ANCA or ASCA diagnoses inflammatory bowel disease
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
inflammatory bowel disease
c
(pre-test probability: 50%)
|
inflammatory bowel disease
(radiology, endoscopy and histology, negative culture)
|
p-ANCA
|
infinity
(4.3 to
infinity)
|
100% |
0.61
(0.57 to
0.66)
|
39% |
children with suspected inflammatory bowel disease a
(pre-test probability: 42%)
|
inflammatory bowel disease
(colonoscopy and histology))
|
ASCA IgA > 20 or IgG > 40 EU/ml, or ANCA > mean 20 EU/ml
|
13
(4.8 to 33)
|
90% |
0.33
(0.22 to 0.50)
|
20% |
|